2010
DOI: 10.1007/s00134-010-2026-y
|View full text |Cite
|
Sign up to set email alerts
|

Rescue treatment for noninvasive ventilation failure due to interface intolerance with remifentanil analgosedation: a pilot study

Abstract: This clinical study suggests that a remifentanil-based sedation protocol can decrease the rate of failure in patients with intolerance to NPPV.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

2
53
0
6

Year Published

2013
2013
2023
2023

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 74 publications
(63 citation statements)
references
References 18 publications
2
53
0
6
Order By: Relevance
“…Taken together, the results of these studies are encouraging [7][8][9][10][11][12][13]. Overall, the use of sedation during NIV appears feasible and safe.…”
mentioning
confidence: 97%
See 3 more Smart Citations
“…Taken together, the results of these studies are encouraging [7][8][9][10][11][12][13]. Overall, the use of sedation during NIV appears feasible and safe.…”
mentioning
confidence: 97%
“…In addition to the present trial [5], several observational studies [7][8][9][10][11] and three randomized trials comparing midazolam and dexmedetomidine or placebo [12][13][14] have assessed the potential use of sedative and/or analgesic drugs to reduce discomfort and risk of NIV failure. The main characteristics and results of these studies are Table 1.…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…Of course there is a serious ethical concern regarding the use of restraints to maintain NIV in agitated patients with treatment-limitation decisions. Some have successfully used a protocol of light sedation with short-acting drugs such as remifentanil to enhance patient comfort and pursue NIV [3,4]. Nevertheless, such ''intervention that deprives patients of their dignity and ability to recognize that family members are present'' may be considered unethical.…”
mentioning
confidence: 99%